Marksans Pharma Goa plant has been inspected by the UK health regulator without any critical observations.
The plant located at Verna has had an inspection by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) from February 14-17, Marksans Pharma said in a filing to BSE today.
“The same has been completed without any critical observations,” it added.
The company, which makes formulations at the facility, is awaiting further instruction from the agency in this regard, Marksans Pharma said.
Marksans Pharma stock was trading sharply up by 19.46 per cent at Rs 48.50 on the BSE.